Jack Bendheim Sells 3,520 Shares of Phibro Animal Health (NASDAQ:PAHC) Stock

Phibro Animal Health Corporation (NASDAQ:PAHC) CEO Jack Bendheim sold 3,520 shares of the stock in a transaction that occurred on Tuesday, October 28th. The stock was sold at an average price of $41.56, for a total value of $146,291.20. Following the sale, the chief executive officer directly owned 51,480 shares of the company’s stock, valued at approximately $2,139,508.80. The trade was a 6.40% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.

Jack Bendheim also recently made the following trade(s):

• On Thursday, October 30th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.07, for a total value of $144,566.40.
• On Thursday, October 23rd, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.18, for a total value of $141,433.60.
• On Wednesday, October 22nd, Jack Bendheim sold 11,859 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.27, for a total value of $477,561.93.
• On Monday, October 20th, Jack Bendheim sold 16,075 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.38, for a total value of $649,108.50.
• On Friday, October 17th, Jack Bendheim sold 700 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.03, for a total value of $28,021.00.
• On Thursday, September 18th, Jack Bendheim sold 7,022 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.26, for a total value of $282,705.72.
• On Wednesday, September 10th, Jack Bendheim sold 3,520 shares of Phibro Animal Health stock. The stock was sold at an average price of $41.29, for a total transaction of $145,340.80.
• On Tuesday, September 9th, Jack Bendheim sold 14,080 shares of Phibro Animal Health stock. The stock was sold at an average price of $40.33, for a total transaction of $567,846.40.

Phibro Animal Health Price Performance

Shares of PAHC opened at $42.06 on Friday. The stock has a market capitalization of $1.70 billion, a P/E ratio of 35.64, a P/E/G ratio of 1.24 and a beta of 0.83. Phibro Animal Health Corporation has a twelve month low of $16.16 and a twelve month high of $43.65. The company has a 50 day moving average of $38.89 and a 200-day moving average of $29.95. The company has a quick ratio of 1.25, a current ratio of 2.76 and a debt-to-equity ratio of 2.46.

Phibro Animal Health (NASDAQ:PAHC) last issued its quarterly earnings results on Wednesday, August 27th. The company reported $0.57 earnings per share for the quarter, topping the consensus estimate of $0.52 by $0.05. The company had revenue of $378.70 million during the quarter, compared to analysts’ expectations of $362.24 million. Phibro Animal Health had a net margin of 3.73% and a return on equity of 32.14%. Phibro Animal Health has set its FY 2026 guidance at 2.520-2.700 EPS. As a group, equities research analysts forecast that Phibro Animal Health Corporation will post 1.95 EPS for the current fiscal year.

Institutional Investors Weigh In On Phibro Animal Health

Several hedge funds have recently added to or reduced their stakes in PAHC. Nuveen LLC acquired a new stake in Phibro Animal Health during the 1st quarter valued at $10,312,000. Capricorn Fund Managers Ltd acquired a new stake in Phibro Animal Health during the 3rd quarter valued at $10,233,000. Allspring Global Investments Holdings LLC acquired a new stake in shares of Phibro Animal Health during the third quarter worth $8,931,000. Invesco Ltd. boosted its position in shares of Phibro Animal Health by 92.3% in the first quarter. Invesco Ltd. now owns 387,739 shares of the company’s stock valued at $8,282,000 after acquiring an additional 186,087 shares during the period. Finally, Ranger Investment Management L.P. grew its stake in shares of Phibro Animal Health by 101.1% in the second quarter. Ranger Investment Management L.P. now owns 357,970 shares of the company’s stock valued at $9,143,000 after acquiring an additional 179,975 shares in the last quarter. Institutional investors and hedge funds own 99.34% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on PAHC shares. Bank of America raised their price target on shares of Phibro Animal Health from $19.00 to $27.00 and gave the stock an “underperform” rating in a research note on Friday, August 29th. Zacks Research raised shares of Phibro Animal Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 29th. Weiss Ratings reissued a “hold (c)” rating on shares of Phibro Animal Health in a research note on Tuesday, October 14th. JPMorgan Chase & Co. raised shares of Phibro Animal Health from a “neutral” rating to an “overweight” rating and raised their target price for the company from $25.00 to $35.00 in a research note on Monday, July 7th. Finally, Morgan Stanley set a $34.00 target price on shares of Phibro Animal Health in a research note on Thursday, August 28th. One research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating, four have given a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $28.40.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.